Medtronic announced today that it submitted 510(k) applications to the FDA seeking clearance for an interoperable insulin ...

Ypsomed announced today that it agreed to sell its diabetes care business to TecMed for up to approximately $517.7 million ...

Medtronic initially won FDA approval in August for its next-generation Simplera CGM. The Simplera platform includes the ...

Abbott recently launched a smartphone app that works with both its FreeStyle Libre 2 and FreeStyle Libre 3 CGM systems.

Biolinq has completed its pivotal trial and submitted its wearable biosensor to the FDA for regulatory review.